Prediabetes is associated with glomerular hyperfiltration in a European Mediterranean cohort study.

Journal of Nephrology
Antonio Rodriguez-PoncelasMaria Antònia Barceló

Abstract

Glomerular hyperfiltration is well recognized as an early renal alteration in subjects with diabetes mellitus. However, what is not well-known is whether hyperfiltration also occurs in the early stages of hyperglycaemia, for instance in prediabetes. Identifying subjects with glomerular hyperfiltration from among those with prediabetes might be helpful to implement preventive and therapeutic strategies. This study aimed to investigate the association of prediabetes with glomerular hyperfiltration and its associated variables. A representative sample of 9238 people aged ≥ 30 years and whose entire clinical and laboratory data were available, were included in this study. Hyperfiltration was defined as an estimated glomerular filtration rate (eGFR) above the age- and gender-specific 95th percentile. The eGFR was assessed using the Chronic Kidney Disease Epidemiology Collaboration equation. After adjustment for age, gender, body mass index, systolic blood pressure and diastolic blood pressure, cholesterol, log (triglycerides), high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, serum uric acid, smoking status, hypertension, and use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, f...Continue Reading

References

Jun 1, 1996·Kidney International·B M BrennerH S Mackenzie
Jan 30, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Gere Sunder-Plassmann, Walter H Hörl
Mar 3, 2007·Kidney International·M TomaszewskiA F Dominiczak
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Feb 3, 2011·Cardiovascular Research·Silvia S BarbieriElena Tremoli
Dec 6, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Rieko OkadaSeiichi Matsuo
Jul 10, 2012·Diabetes Care·Piero RuggenentiUNKNOWN GFR Study Investigators
Jan 4, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Mar 29, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Luca De NicolaRoberto Minutolo
Jan 9, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Francois CachatHassib Chehade
Jan 24, 2015·American Journal of Nephrology·Toralf MelsomBjørn Odvar Eriksen
Jun 8, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Petter BjornstadDavid M Maahs
Sep 20, 2015·The Journal of Clinical Hypertension·Juan-José Rodríguez-Arias, Gabriel Coll-de-Tuero
Oct 29, 2015·The New England Journal of Medicine·Mauro TancrediMarcus Lind
Jan 9, 2016·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Toralf MelsomBjørn Odvar Eriksen
Feb 20, 2017·Journal of Nephrology·Csaba P KovesdyUNKNOWN World Kidney Day Steering Committee
Aug 26, 2017·Journal of Nephrology·Letizia ZeniRobert J Unwin

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.